Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors

This publication has 43 references indexed in Scilit:

• Prostate cancer: molecular biology of early progression to androgen independence.
  Endocrine-Related Cancer, 1999
• TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVO
  Journal of Urology, 1999
• THE BIOLOGY OF HORMONE REFRACTORY PROSTATE CANCER
  Urologic Clinics of North America, 1999
• Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells
  Proceedings of the National Academy of Sciences, 1998
• Vasoactive Intestinal Polypeptide (VIP) and Neuropeptide Tyrosine (NPY) in Prostate Carcinoma
  European Journal Of Cancer, 1997
• Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells*1
  Human Pathology, 1995
• Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.
  Proceedings of the National Academy of Sciences, 1994
• Neuroendocrine differentiation in human prostatic carcinoma
  Human Pathology, 1992
• Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
  The Prostate, 1991
• Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands
  Pathology - Research and Practice, 1986